DLHL
RIGL icon

Donald L. Hagan LLC’s Rigel Pharmaceuticals RIGL Stock Holding History

Donald L. Hagan LLC’s Portfolio RIGL Stock Details RIGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-2,000
Closed -$61K – 381
2015
Q4 		$61K Hold
2,000
– – 0.06% 70
2015
Q3 		$49K Hold
2,000
– – 0.04% 144
2015
Q2 		$64K Buy
+2,000
New +$76.4K 0.06% 72

Other funds holding RIGL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Donald L. Hagan LLC's RIGL Position: Q1 2016 in Review

Donald L. Hagan LLC sold out of Rigel Pharmaceuticals (RIGL) in Q1 2016, closing a stake of 2,000 shares — an estimated $61K sold.

Donald L. Hagan LLC first reported a position in RIGL in Q2 2015 and held it in 3 quarters. The position peaked at $64K in Q2 2015. 120 funds tracked by Wall St. Rank hold RIGL as of Q1 2016.

  • Donald L. Hagan LLC reported no remaining Rigel Pharmaceuticals position as of Q1 2016 after selling out during the quarter.
  • Donald L. Hagan LLC sold 2,000 Rigel Pharmaceuticals shares in Q1 2016, an estimated $61K.
  • Donald L. Hagan LLC first reported a position in Rigel Pharmaceuticals in Q2 2015 and held it in 3 quarters.
  • Donald L. Hagan LLC's Rigel Pharmaceuticals position peaked at $64K in Q2 2015.
  • 120 funds tracked by Wall St. Rank held Rigel Pharmaceuticals as of Q1 2016.

Based on Donald L. Hagan LLC's 13F filing for Q1 2016, filed 14 Apr 2016.